Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1993-4-8
|
pubmed:abstractText |
We have shown that a heptapeptide which resides in the middle part of vitronectin (VN) is responsible for binding to plasminogen activator inhibitor-1 (PAI-1). A single PAI-1 binding peptide was isolated from human VN after limited proteolysis with protease V8. The amino acid sequence of the fragment corresponded to residues Gly-115-Glu-121 of VN. A murine monoclonal antibody (JYV-1) raised against human VN bond to the same fragment and inhibited binding of PAI-1 to VN. A synthetic peptide (V-115), comprising residues Gly-115-Glu-121 of human VN, competed with VN for both PAI-1 and JYV-1 in a dose-dependent manner. Synthetic peptide V-111 (Ser-111-Glu-121) had a stronger inhibitory effect than V-115 on binding of PAI-1 or JYV-1 to VN. V-111 also inhibited the binding of human PAI-1 to mouse and rabbit VN. The functional half-life of PAI-1 activity was prolonged approximately 2-fold in the presence of V-111 (1 mM). This stabilizing effect of V-111 was equivalent to intact VN, although a 1000-fold higher molar concentration of V-111 over VN was required. These data indicated that VN residues Gly-115-Glu-121 contain a PAI-1 binding site.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Matrix Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Vitronectin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2314-20
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7680229-Amino Acid Sequence,
pubmed-meshheading:7680229-Animals,
pubmed-meshheading:7680229-Antibodies, Monoclonal,
pubmed-meshheading:7680229-Binding Sites,
pubmed-meshheading:7680229-Binding Sites, Antibody,
pubmed-meshheading:7680229-Extracellular Matrix Proteins,
pubmed-meshheading:7680229-Glycoproteins,
pubmed-meshheading:7680229-Humans,
pubmed-meshheading:7680229-Mice,
pubmed-meshheading:7680229-Molecular Sequence Data,
pubmed-meshheading:7680229-Oligopeptides,
pubmed-meshheading:7680229-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:7680229-Rabbits,
pubmed-meshheading:7680229-Sequence Homology, Amino Acid,
pubmed-meshheading:7680229-Vitronectin
|
pubmed:year |
1993
|
pubmed:articleTitle |
Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectin.
|
pubmed:affiliation |
Institute of Hematology, Jichi Medical School, Tochigi-ken, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|